Skip to main content

Table 1 Clinical and Metabolic characteristics of subjects

From: The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis

Variable

Non-Diabetics

Diabetics

P-Value

N

462

271

 

Age (years)

45.03 ± 11.52

52.73 ± 11.45

0.000

Systolic BP (mmHg)

120.57 ± 18.23

130.17 ± 19.74

0.000

Diastolic BP (mmHg)

78.15 ± 11.65

82.27 ± 10.71

0.000

BMI (kg/m2)

28.91 ± 6.07

30.15 ± 6.62

0.011

LDL (mmol/L)

3.63 ± 1.31

3.47 ± 1.55

0.17

HDL (mmol/L)

0.91 ± 0.45

0.80 ± 0.32

0.000

Non-HDL (mmol/L)

4.36 ± 1.47

4.67 ± 1.54

0.009

Total Cholesterol (mmol/Ll)

5.26 ± 1.39

5.52 ± 1.74

0.04

Triglycerides (mmol/L)

1.74 ± 1.06

2.63 ± 1.37

0.000

  1. * Data are presented as mean ± SD; p-value significant at < 0.05